Data / Drug companies / Fresenius Kabi iPSUM S.r.l.
Fresenius Kabi iPSUM S.r.l.: 24 products in the FDA NDC directory, labeler code 66558
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fresenius Kabi iPSUM S.r.l. (labeler code 66558) lists 24 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients, 5 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on August 30, 2024.
The request: Watch Fresenius Kabi iPSUM S.r.l. (FDA labeler code 66558): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66558
- Products in commercial distribution
- 24
- Packages
- 47
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 8, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 79.2% |
| Drugs for further processing | 5 | 20.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 79.2% |
| Drugs for further processing | 5 | 20.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 24 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Penicillin g benzathine | 66558-0198 | Powder | Bulk ingredients | August 30, 2024 |
| Icatibant acetate | 66558-0197 | Powder | Bulk ingredients | January 2, 2024 |
| Calcitonin salmon | 66558-0196 | Powder | Bulk ingredients | January 2, 2024 |
| Ceftazidime, avibactam sodium | 66558-0212 | Powder | Drugs for further processing | May 19, 2023 |
| Glucagon | 66558-0195 | Powder | Bulk ingredients | October 1, 2022 |
| Degarelix acetate | 66558-0194 | Powder | Bulk ingredients | October 1, 2022 |
| Cloxacillin sodium | 66558-0211 | Powder | Bulk ingredients | July 29, 2022 |
| Pivmecillinam hydrochloride | 66558-0210 | Powder | Bulk ingredients | June 30, 2022 |
| Amdinocillin | 66558-0207 | Powder | Bulk ingredients | June 30, 2022 |
| Piperacillin sodium, tazobactam sodium, sodium citrate | 66558-0209 | Powder | Drugs for further processing | April 30, 2022 |
| Amoxicillin sodium | 66558-0200 | Powder | Bulk ingredients | November 20, 2021 |
| Liraglutide | 66558-0193 | Powder | Bulk ingredients | June 1, 2021 |
| Octreotide acetate | 66558-0192 | Powder | Bulk ingredients | May 1, 2021 |
| Piperacillin sodium, tazobactam sodium | 66558-0208 | Powder | Drugs for further processing | October 20, 2020 |
| Cefepime | 66558-0204 | Powder | Bulk ingredients | February 12, 2018 |
| Oxacillin sodium | 66558-0203 | Powder | Bulk ingredients | January 25, 2017 |
| Penicillin g sodium | 66558-0170 | Powder | Bulk ingredients | November 11, 2014 |
| Ampicillin trihydrate | 66558-0060 | Powder | Bulk ingredients | December 22, 2011 |
| Cloxacillin benzathine | 66558-0205 | Powder | Bulk ingredients | December 12, 2011 |
| Hetacillin potassium | 66558-0206 | Powder | Bulk ingredients | October 28, 2011 |
| Ampicillin sodium, sulbactam sodium | 66558-0201 | Powder | Drugs for further processing | July 4, 2011 |
| Ampicillin sodium | 66558-0080 | Powder | Bulk ingredients | June 2, 2011 |
| Nafcillin sodium | 66558-0202 | Powder | Bulk ingredients | May 11, 2011 |
| Piperacillin sodium, tazobactam sodium | 66558-0150 | Powder | Drugs for further processing | December 8, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.